Market Brief
China's Jiangsu Zenji (Zhengji) Pharmaceutical to Increase 2020 Capex, an Industrial Info Market Brief
Jiangsu Zenji (Zhengji) Pharmaceutical will ratchet up its capital expenditures next year to $155 million, executives with the specialty producer said recently. Permitting was finalized during the fourth quarter for the company's planned active pharmaceutical ingredients (Levocarnitine Oral Solution, DL-Thioctic acid) grassroot plant in Shandong, China.
Released Wednesday, October 30, 2019
Reports related to this article:
Jiangsu Zenji (Zhengji) Pharmaceutical will ratchet up its capital expenditures next year to $155 million, executives with the specialty producer said recently. Permitting was finalized during the fourth quarter for the company's planned active pharmaceutical ingredients (Levocarnitine Oral Solution, DL-Thioctic acid) grassroot plant in Shandong, China.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Africa's Fertilizer Demand Sparks $5.8 Billion of ProjectsApril 28, 2021
-
Poland's PGE Plans $7 Billion Renewable Energy PushApril 28, 2021
-
Industrial Construction Activity Up 37% So Far in 2021April 26, 2021
Industrial Project Opportunity Database and Project Leads
Get access to verified capital and maintenance project leads to power your growth.
Discover Our DatabaseIndustry Intel
-
The Role of Contract Manufacturing in Global Pharma GrowthPodcast Episode / May 8, 2026
-
2026 North American Labor OutlookPodcast Episode / Apr 24, 2026
-
2026 European Metals & Minerals Project Spending OutlookPodcast Episode / Apr 7, 2026
-
The Age of Critical Minerals in the AmericasPodcast Episode / Mar 20, 2026
-
2026 Regional Chemical Processing OutlookPodcast Episode / Mar 6, 2026